Basilea awarded CARB-X grant of up to USD 2 7 million to develop novel-class antibiotic streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Basilea awarded CARB-X grant of up to USD 2 7 million to develop novel-class antibiotic streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Basilea awarded CARB-X grant of up to USD 2 7 million to develop novel-class antibiotic biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
BOSTON and LONDON, May 5, 2021 /PRNewswire/ The Dementia Discovery Fund (DDF), the venture capital fund investing in, and creating, biotech companies pursuing transformational therapeutic